A COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN IN COMBINATION WITH ACETYLSALICYLIC ACID (ASA) IN ADULT PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR SYMPTOMATIC PERIPHERAL ARTERY DISEASE (PAD) AT HIGH RISK OF ISCHAEMIC EVENTS

被引：0
|
作者：
Pinheiro, B. [1 ]
Gouveia, M. [2 ]
Alarcao, J. [1 ]
Ascencao, R. [1 ]
Borges, M. [3 ]
机构：
[1] Univ Lisbon, Ctr Estudos Med Baseada Evidencia, Fac Med, Lisbon 11, Portugal
[2] Catolica Lisbon Sch Business & Econ, Lisbon 11, Portugal
[3] Univ Lisbon, Fac Med, Lab Farmacol Clin & Terapeut, Lisbon, Portugal
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSB50
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [31] Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy
    Ferrara, Pietro
    Cortesi, Paolo A.
    Di Laura, Danilo
    Maggioni, Aldo P.
    Mantovani, Lorenzo G.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 459 - 468
  • [32] Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy
    Pietro Ferrara
    Paolo A. Cortesi
    Danilo Di Laura
    Aldo P. Maggioni
    Lorenzo G. Mantovani
    Clinical Drug Investigation, 2021, 41 : 459 - 468
  • [33] Type 2 diabetes and risk of cardiovascular events in peripheral artery disease versus coronary artery disease patients
    Sprenger, L.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Maechler, M.
    Klement, M.
    Zanolin-Purin, D.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S315 - S315
  • [34] Type 2 Diabetes and Risk of Cardiovascular Events in Peripheral Artery Disease versus Coronary Artery Disease Patients
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Klement, Margaretha
    Zanolin-Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    CIRCULATION, 2020, 142
  • [35] Type 2 diabetes and risk of cardiovascular events in peripheral artery disease versus coronary artery disease patients
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Klement, Margaretha
    Zanolin-Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S354 - S354
  • [36] TYPE 2 DIABETES AND RISK OF CARDIOVASCULAR EVENTS IN PERIPHERAL ARTERY DISEASE VERSUS CORONARY ARTERY DISEASE PATIENTS
    Sprenger, L.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Maechler, M.
    Mutschlechner, B.
    Klement, M.
    Zanolin-Purin, D.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    ATHEROSCLEROSIS, 2021, 331 : E199 - E199
  • [37] Brachial artery endothelial function and the presence of symptomatic cerebral, peripheral and coronary artery disease in high-risk patients
    Bots, ML
    Witte, DR
    Van der Graaf, Y
    Grobbee, DE
    CIRCULATION, 2003, 107 (07) : E7030 - E7030
  • [38] Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test
    Itoga, Nathan K.
    Minami, Hataka R.
    Chelvakumar, Meenadachi
    Pearson, Keon
    Mell, Matthew M.
    Bendavid, Eran
    Owens, Douglas K.
    VASCULAR MEDICINE, 2018, 23 (02) : 97 - 106
  • [39] Cost-effectiveness analysis of asymptomatic peripheral artery disease screening in primary care
    Ferrat, Emilie
    Moreau, Alain
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2015, 26 (118): : 6S - 7S
  • [40] A cost-effectiveness evaluation of amlodipine usage in patients with coronary artery disease in Sweden
    Doyle, JJ
    McGuire, A
    Arocho, R
    Arikian, S
    Casciano, J
    Svangren, P
    Casciano, R
    Kim, R
    Kugel, H
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (02) : 76 - 81
12345